InterCure - NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds | Maya - TASE Site

Funding Rounds

▤ Summary

InterCure is securing NIS 22 million through a private placement financing round. The deal is being led by pharma-focused hedge funds, which points to investor confidence in the company’s life sciences business. This is a capital event rather than a product, acquisition, or personnel update. The news is relevant to software audiences only because it involves a pharma company, but the article itself does not describe any software offering or SaaS move.

$ Funding

$
Amount $7.4M Total raised
□
Date June 22, 2026 Announcement date
◎
Investors - Lead investors
▥
Company https://www.intercure.co Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies